A novel polypeptide-human interleukin receptor-ligand (IL-17B and IL17BR) 32.56 and polynucleotide for coding said polypeptide


Application Number: 00125085
Application Date: 2000.09.07
Publication Number: 1341660
Publication Date: 2002.03.27
Priority Information:
International: A61K31/7088;A61K38/16;A61K38/17;A61K39/395;A61P29/00;A61P31/00;A61P35/00;A61P43/00;C07H21/00;C07K14/00;C07K14/435;C07K16/00;C07K16/18;C12N15/10;C12N15/11;C12N15/12;C12N15/63;C12N15/64;C12P21/00;C12Q1/68;G01N33/68
Applicant(s) Name: Shanghai Bode Gene Development Co. Ltd.
Address:
Inventor(s) Name: Mao Yumin;Xie Yi
Patent Agency Code: 00000
Patent Agent:
Abstract The present invention discloses a novel polypeptide-human interleukin receptor-ligand (IL-17B and IL-17BR) 32.56, polynucleotide for coding said polypeptide and method for producing this polypeptide by using DNA recombination technology. Said invnetion also discloses the method for curing several diseases, such as rheumatic arthritis, inflammation, immunological disease, various tumors and development disturbance by using said polypeptide. Said invention also discloses an antagonist for resisting said polypeptide and its therapeutic action, and also discloses the application of polynucleotide for coding this novel human interleukin receptor-ligand (IL-17B and IL-17BR) 32.56.